ARTV

Artiva Biotherapeutics
ARTV

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$18.67
466% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Emily Bodnar
50% 1-yr ARTV win rate
12 Nov ‘25 1 month ago
Wedbush
Wedbush
Martin Fan
50% 1-yr ARTV win rate
17 Oct ‘25 1 month ago
Needham
Needham
Gil Blum
50% 1-yr ARTV win rate
17 Oct ‘25 1 month ago